SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

Exagen Q1 Net Loss Widens, Reaffirms Full-Year Revenue Guidance

05/11/2021 13:11

05:02 PM EDT, 05/11/2021 (MT Newswires) -- Exagen (XGN) reported Tuesday a Q1 net loss of $0.48 per share, compared with a loss of $0.44 per share a year earlier.

Analysts polled by Capital IQ expected a net loss per share of $0.45.

Revenue totaled $10.6 million, up from $9.6 million a year earlier. The Street forecast was for $10.5 million.

The company reaffirmed its full-year revenue guidance of between $47 million and $49 million, versus the consensus estimate of $48 million.

Price: 15.06, Change: -0.11, Percent Change: -0.73